Department of Medicine

(FEBRUARY 28, 2023) James Gerson, M.D., assistant professor of medicine and director of the CAR T-Cell Program, spoke to the Press-Republican about the promising cancer treatment called CAR T-cell therapy that is now available at the UVM Cancer Center.

The University of Vermont’s Larner College of Medicine features some of the world’s foremost cardiovascular researchers, experts in cardiovascular disease risk factors, thrombosis, atherosclerosis, stroke, and heart failure. the science shared by early-career investigators at the Cardiovascular Research Institute of Vermont’s fourth annual Viridis Montis Challenge, it was apparent that the institution’s reputation and legacy in the field of cardiovascular research will continue to have a global impact.